Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Harpel

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|April 10, 1985
Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin IP C Harpel, T S Chang, E Verderber
The Journal of Cell Biology|June 1, 1991
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migrationS Kojima, P C Harpel, D B Rifkin
The Journal of Biological Chemistry|July 28, 1995
Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase-modified human plasminogenE Bendixen, P C Harpel, L Sottrup-Jensen
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1992
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolismP C Harpel, V T Chang, W Borth
Blood|September 1, 1985
Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assayA P Kaplan, B Gruber, P C Harpel
The Journal of Biological Chemistry|January 5, 1989
Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragmentP C Harpel, R Sullivan, T S Chang
Protein Science : a Publication of the Protein Society|February 12, 1998
Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding siteA Hermann, W R Laws, P C Harpel
Analytical Biochemistry|May 15, 1984
Measurement of human activated factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assayJ Jesty, S A Morrison, P C Harpel
The Journal of Clinical Investigation|October 1, 1987
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cellsB S Knudsen, P C Harpel, R L Nachman
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaP C Harpel, T E Hugli, N R Cooper
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|April 10, 1985
Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin IP C Harpel, T S Chang, E Verderber
The Journal of Cell Biology|June 1, 1991
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migrationS Kojima, P C Harpel, D B Rifkin
The Journal of Biological Chemistry|July 28, 1995
Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase-modified human plasminogenE Bendixen, P C Harpel, L Sottrup-Jensen
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1992
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolismP C Harpel, V T Chang, W Borth
Blood|September 1, 1985
Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assayA P Kaplan, B Gruber, P C Harpel
The Journal of Biological Chemistry|January 5, 1989
Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragmentP C Harpel, R Sullivan, T S Chang
Protein Science : a Publication of the Protein Society|February 12, 1998
Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding siteA Hermann, W R Laws, P C Harpel
Analytical Biochemistry|May 15, 1984
Measurement of human activated factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assayJ Jesty, S A Morrison, P C Harpel
The Journal of Clinical Investigation|October 1, 1987
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cellsB S Knudsen, P C Harpel, R L Nachman
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaP C Harpel, T E Hugli, N R Cooper
Pageof 9